05/10
Headlines

GERN

Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

John Bellich03 mins

Geron Corporation (NASDAQ:GERN) on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity that was identified in clinical trials of…

Read More

Healthcare Active Movers: Geron Corporation (NASDAQ:GERN), Merck (NYSE:MRK), Valeant Pharmaceuticals (NYSE:VRX), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX)

Jayne Crisman03 mins

Geron Corporation (NASDAQ:GERN) was one of the Nasdaq’s most active movers, jumping 23 per cent to $3.20 on heavy volume after the US Food and Drug Administration lifted a partial clinical hold on a study testing its blood cancer drug. Geron Corporation (NASDAQ:GERN) stock performance was 21.15% in last session and finished the day at…

Read More

NASDAQ Movers: Yahoo! Inc. (NASDAQ:YHOO), Geron Corporation (NASDAQ:GERN), American Airlines Group (NASDAQ:AAL), Galena Biopharma (NASDAQ:GALE), Micron Technology (NASDAQ:MU)

Jayne Crisman03 mins

Search and media site Yahoo! Inc (NASDAQ:YHOO)  gains modestly Wednesday as its partner, China’s Alibaba Group, rolls out a beta version of a U.S. e-commerce site, Reuters reported. YHOO holds a significant stake in Alibaba, valued recently at about $26 billion.  Yahoo! Inc. (NASDAQ:YHOO) stock performance was 0.55% in last session and finished the day at…

Read More